ImmunoACT

  • Company Size 51-200
  • Company Location Navi Mumbai, Maharashtra
  • Total Funding $17.18 Mn+
  • # of Clients NA

About ImmunoACT

Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer of Gene-modified Cell Therapies, having launched the country's first CAR-T cell therapy for treatment of certain B-cell malignancies. With a rapidly expanding pipeline beginning, our mission is to provide affordable access to novel CAR-T cell therapies.

Solutions

  • Lifescience
  • Gene Therapies
  • CAR-T cell therapy

Client Type

    No Record Found

You May be Interested In

  • Engagement Suite
  • Adaptive Call Center Automation
  • Request Demo
Show Rating
Write a Review
No Data Found

Related Articles